Randomized Phase II Trial of Rituximab With Either Pentostatin or Bendamustine for Multiply Relapsed or Refractory Hairy Cell Leukemia

NCT01059786 · clinicaltrials.gov ↗

PHASE2

Phase

ACTIVE_NOT_RECRUITING

Status

69

Enrollment

NIH

Sponsor class

Conditions

Hairy Cell Leukemia

Interventions

DRUG: Pentostatin
DRUG: Rituximab
DRUG: Bendamustine
DRUG: Acetaminophen
DRUG: Diphenhydramine
DRUG: Epinephrine
DRUG: Antihistamines
DRUG: Corticosteroids
DRUG: Bronchodilators
OTHER: Intravenous (IV) Saline

Sponsor

National Cancer Institute (NCI)